Novo Nordisk A/S (Novo Nordisk A/S) Operating Cash Flow per Share : $3.49 (TTM As of Dec. 2023)

View and export this data going back to 1981. Start your Free Trial

What is Novo Nordisk A/S Operating Cash Flow per Share?

Novo Nordisk A/S's operating cash flow per share for the three months ended in Dec. 2023 was $0.31. Novo Nordisk A/S's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.49.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Novo Nordisk A/S was 39.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 20.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Novo Nordisk A/S's Operating Cash Flow per Share or its related term are showing as below:

NVO' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -46.4 Med: 16.5 Max: 136.2
Current: 29.7

During the past 13 years, Novo Nordisk A/S's highest 3-Year average Operating Cash Flow per Share Growth Rate was 136.20% per year. The lowest was -46.40% per year. And the median was 16.50% per year.

NVO's 3-Year OCF Growth Rate is ranked better than
79.06% of 1237 companies
in the Biotechnology industry
Industry Median: 3.5 vs NVO: 29.70

Novo Nordisk A/S Operating Cash Flow per Share Historical Data

The historical data trend for Novo Nordisk A/S's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Operating Cash Flow per Share Chart

Novo Nordisk A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.46

1.82

1.81

2.47

3.55

Novo Nordisk A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.22	0.95	0.92	1.31	0.31

Competitive Comparison of Novo Nordisk A/S's Operating Cash Flow per Share

For the Biotechnology subindustry, Novo Nordisk A/S's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novo Nordisk A/S's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Price-to-Operating-Cash-Flow falls into.

Novo Nordisk A/S Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Novo Nordisk A/S's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	15934.336	/	4494.800
	=	3.55

Novo Nordisk A/S's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	1397.407	/	4474.400
	=	0.31

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.49

Novo Nordisk A/S Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

NONOF:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, DK-2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.